BJDX (Bluejay Diagnostics) Inventories, Inventories Adjustments: $ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJDX Bluejay Diagnostics Inc BJDX
26 GF Score
Price $0.99
! 1 Warning Sign
View Full Analysis

What is Bluejay Diagnostics Inventories, Inventories Adjustments?

Bluejay Diagnostics BJDX +8.50% 26 Inventories, Inventories Adjustments is $ Mil as of Jun. 2026. GuruFocus rates BJDX with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Bluejay Diagnostics's Inventories, Inventories Adjustments for the quarter that ended in Jun. 2026 was $ Mil.

Bluejay Diagnostics Inventories, Inventories Adjustments Historical Data

* Premium members only.

The historical data trend for Bluejay Diagnostics's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bluejay Diagnostics Inventories, Inventories Adjustments Chart

Bluejay Diagnostics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Inventories Adjustments
Get a 7-Day Free Trial - - - - -

Bluejay Diagnostics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Inventories Adjustments Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
BJDX
26GF Score
Bluejay Diagnostics Inc BJDX
Inventories, Inventories Adjustments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bluejay Diagnostics Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.

What does a Inventories, Inventories Adjustments of $ Mil mean?
Bluejay Diagnostics (BJDX) has a Inventories, Inventories Adjustments of $ Mil as of Jun. 2026. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on Bluejay Diagnostics and its competitors.
Is Bluejay Diagnostics' Inventories, Inventories Adjustments too high?
Bluejay Diagnostics' current Inventories, Inventories Adjustments is $ Mil. Overall, Bluejay Diagnostics has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Bluejay Diagnostics' Inventories, Inventories Adjustments compare to ODYY and VTAK?
Bluejay Diagnostics' Inventories, Inventories Adjustments of $ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Inventories Adjustments for a Medical Devices & Instruments company?
A good Inventories, Inventories Adjustments depends on the Medical Devices & Instruments industry context. However, Inventories, Inventories Adjustments should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Inventories Adjustments mean?
A high Inventories, Inventories Adjustments can signal that a stock is expensive relative to its fundamentals. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on Bluejay Diagnostics and its competitors. Bluejay Diagnostics's current Inventories, Inventories Adjustments is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bluejay Diagnostics stock overvalued right now?
Bluejay Diagnostics (BJDX) has a current Inventories, Inventories Adjustments of $ Mil. The current Inventories, Inventories Adjustments is $ Mil. Bluejay Diagnostics' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Inventories Adjustments calculated?
Inventories, Inventories Adjustments is calculated from a company's financial statements. For Bluejay Diagnostics (BJDX), the current Inventories, Inventories Adjustments is $ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bluejay Diagnostics Business Description

Address 360 Massachusetts Avenue, Suite 203, Acton, MA, USA, 01720
Bluejay Diagnostics Inc. is a medical diagnostics company based in the United States that develops near-patient testing systems intended to improve patient outcomes. Its primary platform is the Symphony System, a rapid, cost-effective testing device designed for use in sepsis triage and monitoring of disease progression. The company's lead product candidate is an IL-6 Test for sepsis, which is designed to deliver accurate results in approximately 20 minutes from sample to result, helping medical professionals make earlier triage and treatment decisions. Bluejay targets hospitals, clinics, and other healthcare providers that require fast diagnostic information at or near the point of care. Its revenue model is expected to be based on sales of the Symphony System instruments and recurring sales of proprietary test cartridges and related consumables. The company is headquartered in the United States and focuses primarily on the domestic healthcare market.
26GF Score

Get the complete analysis for BJDX

Inventories, Inventories Adjustments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.99
Price